109 related articles for article (PubMed ID: 2067873)
1. [The role of growth hormone in the development of complications in insulin-dependent diabetes].
Krawczuk-Rybak M; Urban M
Padiatr Grenzgeb; 1991; 30(3):237-43. PubMed ID: 2067873
[TBL] [Abstract][Full Text] [Related]
2. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
Peczyńska J; Urban M; Głowińska B; Urban B
Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the somatotropic axis in insulin dependent diabetes mellitus.
Mercado M; Baumann G
Arch Med Res; 1995; 26(2):101-9. PubMed ID: 7620273
[TBL] [Abstract][Full Text] [Related]
5. Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization.
Hanaire-Broutin H; Sallerin-Caute B; Poncet MF; Tauber M; Bastide R; Rosenfeld R; Tauber JP
Diabetes Metab; 1996 Jul; 22(4):245-50. PubMed ID: 8767170
[TBL] [Abstract][Full Text] [Related]
6. Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys.
Zachrisson I; Brismar K; Carlsson-Skwirut C; Dahlquist G; Wallensteen M; Bang P
Growth Horm IGF Res; 2000 Dec; 10(6):324-31. PubMed ID: 11161963
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics with or without severe microvascular lesions.
Blickle JF; Schlienger JL; de Laharpe F; Stephan F
Diabete Metab; 1982 Sep; 8(3):197-201. PubMed ID: 6814964
[TBL] [Abstract][Full Text] [Related]
8. Early effects of streptozotocin-induced diabetes on insulin-like growth factor-I in the kidneys of growth hormone-transgenic and growth hormone-deficient dwarf mice.
Jacobs ML; Chandrashekar V; Bartke A; Weber RF
Exp Nephrol; 1997; 5(4):337-44. PubMed ID: 9259189
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between concentration of growth hormone in serum and microangiopathy in patients with diabetes mellitus].
Chen M; Yu W; Hu S
Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):765-7. PubMed ID: 9772523
[TBL] [Abstract][Full Text] [Related]
10. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
Amin R; Williams RM; Frystyk J; Umpleby M; Matthews D; Orskov H; Dalton RN; Dunger DB
Clin Endocrinol (Oxf); 2005 Feb; 62(2):137-44. PubMed ID: 15670188
[TBL] [Abstract][Full Text] [Related]
11. [GH, prolactin and microangiopathy in insulin-dependent diabetes].
Cerutti F; Pagliero R; Ramenghi U; Sacchetti C; Baratono S; Altare F
Minerva Pediatr; 1981 Feb; 33(3):127-30. PubMed ID: 7242486
[No Abstract] [Full Text] [Related]
12. Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus.
Christ ER; Carroll PV; Albany E; Umpleby AM; Lumb PJ; Wierzbicki AS; Sönksen PH; Russell-Jones DL
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1154-62. PubMed ID: 11934682
[TBL] [Abstract][Full Text] [Related]
13. Effects of exercise training on hippocampus concentrations of insulin and IGF-1 in diabetic rats.
Gomes RJ; de Oliveira CA; Ribeiro C; Mota CS; Moura LP; Tognoli LM; Leme JA; Luciano E; de Mello MA
Hippocampus; 2009 Oct; 19(10):981-7. PubMed ID: 19437499
[TBL] [Abstract][Full Text] [Related]
14. IGF-I and diabetes in adolescence.
Dunger DB; Acerini CL
Diabetes Metab; 1998 Apr; 24(2):101-7. PubMed ID: 9592633
[TBL] [Abstract][Full Text] [Related]
15. [Vascular alterations and GH secretion in latent chemical diabetes].
Sgambato S; Carbone L; Bisesti V; Passariello N; Tesauro P; Varano R
Boll Soc Ital Biol Sper; 1979 Feb; 55(3):279-85. PubMed ID: 399851
[TBL] [Abstract][Full Text] [Related]
16. Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes.
Ekström K; Salemyr J; Zachrisson I; Carlsson-Skwirut C; Ortqvist E; Bang P
Diabetes Care; 2007 Jun; 30(6):1357-63. PubMed ID: 17372150
[TBL] [Abstract][Full Text] [Related]
17. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
Savage MO; Dunger DB
Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
[TBL] [Abstract][Full Text] [Related]
18. [Somatotropic hormone, diabetes and diabetic angiopathy].
Dobrev DG
Vutr Boles; 1979; 18(5):21-7. PubMed ID: 390884
[No Abstract] [Full Text] [Related]
19. Growth hormone's role in diabetic microangiopathy.
Lundbaek K
Diabetes; 1976; 25(2 SUPPL):845-9. PubMed ID: 985606
[TBL] [Abstract][Full Text] [Related]
20. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis.
Holt RI; Simpson HL; Sönksen PH
Diabet Med; 2003 Jan; 20(1):3-15. PubMed ID: 12519314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
